Search research articles
Contact Us
Filters
Showing results (181-190 of 211) with videos related to
Page
of 22
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)
|
December 29, 2010
Daratumumab, a novel therapeutic human CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological tumors
Michel de Weers, Yu-Tzu Tai, Michael S van der Veer, et al.
Blood Advances
|
October 15, 2021
Clonal phylogeny and evolution of critical cytogenetic aberrations in multiple myeloma at single-cell level by QM-FISH
Yuting Yan, Xiaoqi Qin, Jiahui Liu, et al.
Blood
|
March 19, 2020
YWHAE/14-3-3ε expression impacts the protein load, contributing to proteasome inhibitor sensitivity in multiple myeloma
Yan Xu, Mariateresa Fulciniti, Mehmet K Samur, et al.
Blood Advances
|
November 8, 2019
Rational design of a trimeric APRIL-based CAR-binding domain enables efficient targeting of multiple myeloma
Andrea Schmidts, Maria Ormhøj, Bryan D Choi, et al.
Blood
|
October 2, 2007
Anti-CS1 humanized monoclonal antibody HuLuc63 inhibits myeloma cell adhesion and induces antibody-dependent cellular cytotoxicity in the bone marrow milieu
Yu-Tzu Tai, Myles Dillon, Weihua Song, et al.
Nature Communications
|
August 24, 2018
Genomic patterns of progression in smoldering multiple myeloma
Niccolò Bolli, Francesco Maura, Stephane Minvielle, et al.
Nature Medicine
|
May 26, 2015
The Cyclophilin A-CD147 complex promotes the proliferation and homing of multiple myeloma cells
Di Zhu, Zhongqiu Wang, Jian-Jun Zhao, et al.
Nature Medicine
|
January 25, 2024
Author Correction: The Cyclophilin A-CD147 complex promotes the proliferation and homing of multiple myeloma cells
Di Zhu, Zhongqiu Wang, Jian-Jun Zhao, et al.
Blood
|
June 13, 2012
Bruton tyrosine kinase inhibition is a novel therapeutic strategy targeting tumor in the bone marrow microenvironment in multiple myeloma
Yu-Tzu Tai, Betty Y Chang, Sun-Young Kong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 17, 2015
Lenalidomide Enhances Immune Checkpoint Blockade-Induced Immune Response in Multiple Myeloma
Güllü Görgün, Mehmet K Samur, Kristen B Cowens, et al.
Page
of 22
Search research articles
Search
Showing results (181-190 of 211) with videos related to
Sort By:
Page
of 22
Journal of Immunology (Baltimore, Md. : 1950)
|
December 29, 2010
Daratumumab, a novel therapeutic human CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological tumors
Michel de Weers, Yu-Tzu Tai, Michael S van der Veer, et al.
Blood Advances
|
October 15, 2021
Clonal phylogeny and evolution of critical cytogenetic aberrations in multiple myeloma at single-cell level by QM-FISH
Yuting Yan, Xiaoqi Qin, Jiahui Liu, et al.
Blood
|
March 19, 2020
YWHAE/14-3-3ε expression impacts the protein load, contributing to proteasome inhibitor sensitivity in multiple myeloma
Yan Xu, Mariateresa Fulciniti, Mehmet K Samur, et al.
Blood Advances
|
November 8, 2019
Rational design of a trimeric APRIL-based CAR-binding domain enables efficient targeting of multiple myeloma
Andrea Schmidts, Maria Ormhøj, Bryan D Choi, et al.
Blood
|
October 2, 2007
Anti-CS1 humanized monoclonal antibody HuLuc63 inhibits myeloma cell adhesion and induces antibody-dependent cellular cytotoxicity in the bone marrow milieu
Yu-Tzu Tai, Myles Dillon, Weihua Song, et al.
Nature Communications
|
August 24, 2018
Genomic patterns of progression in smoldering multiple myeloma
Niccolò Bolli, Francesco Maura, Stephane Minvielle, et al.
Nature Medicine
|
May 26, 2015
The Cyclophilin A-CD147 complex promotes the proliferation and homing of multiple myeloma cells
Di Zhu, Zhongqiu Wang, Jian-Jun Zhao, et al.
Nature Medicine
|
January 25, 2024
Author Correction: The Cyclophilin A-CD147 complex promotes the proliferation and homing of multiple myeloma cells
Di Zhu, Zhongqiu Wang, Jian-Jun Zhao, et al.
Blood
|
June 13, 2012
Bruton tyrosine kinase inhibition is a novel therapeutic strategy targeting tumor in the bone marrow microenvironment in multiple myeloma
Yu-Tzu Tai, Betty Y Chang, Sun-Young Kong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 17, 2015
Lenalidomide Enhances Immune Checkpoint Blockade-Induced Immune Response in Multiple Myeloma
Güllü Görgün, Mehmet K Samur, Kristen B Cowens, et al.
Page
of 22